Resources

News

News from Vox.Bio

Five steps to succeeding with suppliers

Better relationships and more explicit expectations between research agencies and their suppliers can help create...

VoxBio team

Healthcare Market Research and Pharma CI: Two Parts of the Same Whole

Strategic decisions for pipeline assets and brands require robust and creative analysis which leaves no...

VoxBio team

Advanced Analytics: Understanding stakeholder preferences through conjoint analysis

Conjoint analysis is a statistical method that can be used to evaluate and measure the...

VoxBio team

Cambridge Healthcare Research appoints Head of Operations Rich McLean, formerly Head of European Operations at Amazon

Rich McLean joins CHR and Vox.Bio as Head of Operations Rich offers the group a...

VoxBio team

CHR for Society shares new logo and branding, making a more impactful presence with their Corporate Social Responsibility framework

Our CSR team is very happy to announce the launch of new branding to accompany...

VoxBio team

COVID-19 Dissecting the Therapeutic and Vaccine Landscape

Anti-virals? Antibodies? Immunomodulators? Vaccines? If you have a functioning pair of eyes and ears, you...

VoxBio team

How We Use Secondary Landscape Analysis to Build Confidence in Our Research Insights

We are coming towards the end of a qualitative research project and so far, so...

VoxBio team

Why focus groups can give you more…

As the pharma space continues on its ever-increasingly competitive trajectory, sometimes understanding the ‘why’ is...

VoxBio team

Key Insights from ESMO 2019

The dust has just started to settle now on ESMO 2019, which certainly delivered when...

VoxBio team

BHBIA Conference 2019

On 13th and 14th May 2019 BHBIA members descended on a hotel in Windsor for...

VoxBio team

We have launched our new London Office!

In January 2018, we opened our first London office, this was a significant step in...

VoxBio team

Managing cancer patients during the COVID-19 pandemic

COVID-19 has impacted all aspects of clinical care globally – no doubt. Amid efforts put...

VoxBio team

‘tis the Season for Giving

With only a few days left until Christmas, Vox.Bio would like to wish happy holidays...

VoxBio team

Rapid Approvals & Innovative Approaches, But Which Sickle Cell Therapies Will Offer Real Benefits?

Sickle cell disease (SCD) currently effects 100,000 patients in the US and about 1 in...

VoxBio team

Vox @ BHBIA 22: Evolution of the NHS

Vox Bio led a panel discussion with Tim Straughan (Director of NHS @home) and Stephen...

VoxBio team

Welcome to our new CEO Chris Stevenson

Vox.Bio and Cambridge Healthcare Research are thrilled to announce the appointment of Chris Stevenson as...

VoxBio team

Mindfulness Event

The arrival of Covid-19 and the resultant lockdowns have placed a large amount of stress...

VoxBio team

Keep Calm and Carry on Researching

With restrictions to travel and the increasing number of medical congresses, sporting and music events...

VoxBio team

Can Digital Health Fundamentally Change Healthcare in APAC?

Digital health is undoubtedly one of the hottest topics in healthcare industry, including in the...

VoxBio team

We are working from home

With the well-being of our staff in mind we have taken the difficult decision to...

VoxBio team

Will PSMA-targeting diagnostics and therapeutics revolutionize Prostate Cancer care?

Prostate cancer (PC) is the fourth most common cancer worldwide, affecting approximately 1.3 million people,...

VoxBio team

Is the US Finally Ready for the Biosimilar Boom?

The emergence of biosimilars has provided promise of increased cost-savings and increased patient accessibility to...

VoxBio team